Join us for the Great Pink Run with Glanbia and help research a cure for breast cancer!
October 5, 2019 at Diversey Harbor
GREAT PINK RUN CHICAGO – RESEARCH PARTNERSHIP
Research A Cure NFP
Research A Cure NFP has been established to support collaborative breast cancer research efforts between US and Irish Centers of Excellence. Combining expertise will maximise patient benefits globally and ultimately change the landscape of breast cancer treatment into the future
Funds generated from this inaugural Great Pink Run Chicago will go directly to support research collaborations between the Ludwig Breast Research Center at the University of Chicago (link to it) and the Breast Cancer Ireland Research Centre at the Royal College of Surgeons in Ireland (link to it )
Under Professor Geoffrey Greene & Dr Gini Fleming, the Ludwig Breast Research Center focuses largely on the causes of metastatic disease, where original treatment for breast cancer now results in a recurrence to, on occasion, another organ or part of the body. Their goal is to discovery ways to inhibit this recurrence is so many diagnosed
Breast Cancer Ireland Research Center Ireland
Breast Cancer Ireland a registered Irish charity, is dedicated to supporting pioneering research into breast cancer and to providing education and awareness programmes on the importance of good breast health for women of all ages. Through research the aim is to transform breast cancer from often being fatal –into a more treatable illness that can be maintained longterm
Working closely with leading scientists, Professor Leonie Young and Dr Damir Vareslija, their team is focusing largely on the causes of metastatic disease and the discovery of new novel ways to inhibit this disease progression.
In addition Breast Cancer Ireland fund various dedicated research fellowships into many breast cancer subtypes eg Triple Negative and HER+ cases.
Professor Geoffrey Greene
Virginia and D. K. Ludwig Professor and Chair
The Ben May Department for Cancer Research
The Department of Biochemistry and Molecular Biology
Associate Director of Basic Science, UCCCC
Committee on Cancer Biology
Ludwig Center for Metastasis Research
Ph.D. Northwestern University, 1974
Prof Leonie Young
The Endocrine Oncology Research Group is lead by Prof Leonie Young and is based at the Royal College of Surgeons in Ireland. Prof Young graduated from Trinity College Dublin and completed her Ph.D. training at University College Dublin.
Prof Young leads a large breast cancer research group, with funding supported by Breast Cancer Ireland and others and has published numerous papers in international peer-reviewed scientific journals and won many internationally acclaimed prizes for ongoing work into breast cancer treatment.
Dr Gini Fleming
Gini Fleming, MD, is an expert in breast and gynecological cancers. Her recent research examines novel therapeutics in breast, ovarian and endometrial cancers.
Dr. Fleming has authored and co-authored more than 100 articles for a variety of medical journals, in addition to a number of textbook chapters. She serves on the editorial board for Gynecologic Oncology.
Dr Damir Vareslija
The main focus of Damir’s research is seeking to understand how breast cancer can become unresponsive to current treatments and to explore what makes the cancer ‘come back’ and metastasise to other parts of the body.
Metastatic disease is the single biggest cause of mortality in breast cancer. The challenge is in understanding and creating pathways that will improve patient treatment strategies and outcomes longterm. Dr Vareslija, who has worked in numerous high profiled institutions inc Dana Faber in Massachusetts , has won many scientific awards and has had his research published in peer reviewed journals internationally.
Run for them!
With 1 in 8 women developing the disease in their lifetime, everybody knows someone that has been affected, whether a family relative, friend, or member within the community – making it all the more important to continue investing in research to help transform breast cancer from often being a fatal disease to a long term treatable illness.
Thank you to our partners